Adjuvant pharmacological strategies for the musculoskeletal system during long‐term space missions
Authors:
Open Access
- 29 August 2023
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 92 (1) , 11-23
Abstract
Despite 2 h of daily exercise training, muscle wasting and bone loss are still present after 6‐month missions to the international space station. Some crew members lose bone much faster than others. In preparation for missions to the Moon and Mars, space agencies are therefore reviewing their countermeasure portfolios. Here, we discuss the potential of current pharmacological strategies. Bone loss in space is fuelled by bone resorption. Alendronate, an oral bisphosphonate, reduced bone losses in experimental bed rest and space. However, gastrointestinal side effects precluded its further utilization in space. Zoledronate (a potent bisphosphonate), denosumab (RANKL antagonist) and romosozumab (sclerostin antagonist) are all administered via injection. They effectively suppress bone resorption and are routinely prescribed against osteoporosis. Their serious adverse effects, namely, osteonecrosis of the jaw and atypical femur fractures occur very rarely when the usage is limited to 1 or 2 years. Hence, utilization of one of these compounds may outweigh the bone risks of space travelling, in particular in those with high bone resorption rates. Muscle wasting in space is likely due to hampered muscle protein synthesis. Even though this might theoretically be countered by the synthesis‐boosting effects of anabolic steroids, the practical grounds for such recommendation are currently weak. Moreover, they reveal their full potential only when combined with an anabolic exercise stimulus, for example, via strength training. It therefore seems that a combination of exercise and pharmacological countermeasures should be considered for musculoskeletal health on the way to the Moon and Mars and back.Keywords
This publication has 140 references indexed in Scilit:
- Skeletal health in long-duration astronauts: Nature, assessment, and management recommendations from the NASA bone summitJournal of Bone and Mineral Research, 2013
- Optic Disc Edema, Globe Flattening, Choroidal Folds, and Hyperopic Shifts Observed in Astronauts after Long-duration Space FlightOphthalmology, 2011
- Prolonged space flight-induced alterations in the structure and function of human skeletal muscle fibresThe Journal of Physiology, 2010
- Prevention of bone loss during 56 days of strict bed rest by side-alternating resistive vibration exerciseBone, 2010
- Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2009
- Disassociation between the effects of amino acids and insulin on signaling, ubiquitin ligases, and protein turnover in human muscleAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Leucine-enriched essential amino acid and carbohydrate ingestion following resistance exercise enhances mTOR signaling and protein synthesis in human muscleAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Alendronate for the Treatment of Osteoporosis in MenNew England Journal of Medicine, 2000
- The Effects of Supraphysiologic Doses of Testosterone on Muscle Size and Strength in Normal MenNew England Journal of Medicine, 1996
- Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle.Journal of Clinical Investigation, 1994